Reduction in proteinuria after immunosuppressive therapy and long-term kidney outcomes in patients with immunoglobulin A nephropathy

BACKGROUND/AIMS: Despite controversy regarding the benefits of immunosuppressive therapy in immunoglobulin A nephropathy (IgAN), clinical outcomes may vary depending on the patient’s responsiveness to this therapy. This study evaluated long-term kidney outcomes according to the extent of proteinuria...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Shin Chan, Kim, Hyung Woo, Chang, Tae Ik, Kang, Ea Wha, Lim, Beom Jin, Park, Jung Tak, Yoo, Tae-Hyun, Jeong, Hyeon Joo, Kang, Shin-Wook, Han, Seung Hyeok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435500/
https://www.ncbi.nlm.nih.gov/pubmed/33561333
http://dx.doi.org/10.3904/kjim.2020.240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435500/
https://www.ncbi.nlm.nih.gov/pubmed/33561333
http://dx.doi.org/10.3904/kjim.2020.240

Ejemplares similares